<DOC>
	<DOCNO>NCT02595684</DOCNO>
	<brief_summary>Obesity chronic disease multifactorial etiology develop interaction influence nutritive , metabolic , cellular molecular psychological factor . Tadalafil Is drug inhibit enzyme phosphodiesterase-5 ( PDE-5 ) , responsible inactivate vasodilator nitric oxide . USING paragraph mainly treat erectile dysfunction , recently approve treatment pulmonary hypertension , innovative long life mean , provide efficacy 36 hour high selectivity . The aim study evaluate effect tadalafil insulin sensitivity insulin secretion obese men . The investigator hypothesis administration tadalafil improve insulin sensitivity insulin secretion obese men .</brief_summary>
	<brief_title>Effect Tadalafil Insulin Secretion Insulin Sensitivity Obese Men .</brief_title>
	<detailed_description>A randomized , double-blind , placebo-controlled clinical trial 18 men age 30 50 year obesity ( BMI 30-39.9 ) accord OMS criterion without treatment . They assign randomly two group 9 patient , receive 5 mg tadalafil placebo every day night 28 day . There evaluated Insulin secretion , first phase insulin secretion Stumvoll Inex well Total Insulin Secretion Area Under Curve glucose insulin Insulinogenic Index , Insulin sensitivity Matsuda index . Waist circumference , glucose insulin level , lipid profile , creatinine acid uric level blood pressure go load evaluate intervention group . Statistical analysis present measure central tendency dispersion , average deviation standard quantitative variable ; frequency percentages variable qualitative . Qualitative variable analyze X2 , use difference inter-group Mann-Whitney U Test Wilcoxon Test within-groups difference . Will consider statistical significance p ≤0.05 . This protocol approve local Ethics Committee write informed consent obtain volunteer .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<criteria>Men Age : 3050 year BMI : 30 39.9 kg/m² No Pharmacotherapy last 3 month Signature Consent Information Cholesterol : ≥ 240 mg / dl Triglycerides : ≥ 400 mg / dl Fasting glucose : ≥ 126 mg / dl Diabetes mellitus . Hypertension Patients renal , liver / thyroid disease Consumption drug know effect glucose insulin metabolism . Use cigar / drug Hypersensitivity tadalafil</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Tadalfil</keyword>
	<keyword>Insulin secretion</keyword>
	<keyword>Insulin sensitivity</keyword>
</DOC>